The XF Analyzer is the first and only commercially available instrument for scientific research that simultaneously measures in real-time and in live cells the two major energy pathways of the cell: mitochondrial respiration and glycolysis. Since 2007 when its patent was issued, the XF Analyzer has been used in laboratories world-wide to more rapidly and more accurately obtain real-time measurements of cellular respiration, oxidative phosphorylation, motility, and transport pathways. Such measurements would be invaluable in gaining insights into the mechanisms of many diseases, including cancer, that are linked to metabolic dysfunction or reprogramming.
Using Seahorse XF Analyzers, we can readily obtain novel and important data from live cells in real time, thereby providing a greater understanding of cell metabolism, and enabling new advancements in life science research.
Richard Kibbey, MD, PhD
Associate Professor of Medicine (Endocrinology) and of Cellular and Molecular Physiology